International Liver Congress

Meeting NewsVideo

VIDEO: Physician discusses importance of Ocaliva license in Europe

April 25, 2017
AMSTERDAM — In this exclusive video from International Liver Congress, Rick Lones, vice president, head of medical affairs for Europe, Canada…
Meeting News

Rituximab not effective for treating fatigue in PBC

April 24, 2017
AMSTERDAM — Rituximab was not effective in treating fatigue in unselected patients with primary biliary cholangitis despite metabolic…
Meeting News

Glecaprevir/pibrentasvir effective in liver, kidney transplant patients with HCV

April 23, 2017
AMSTERDAM — Nearly 100% of a cohort of non-cirrhotic patients with HCV who had undergone liver transplantation responded to treatment with…
Meeting News

Adherence, SVR unaffected by drug use in patients with HCV

April 23, 2017
AMSTERDAM — Adherence to treatment and subsequent sustained virologic response were unaffected by drug use in a study of patients enrolled in…
Meeting NewsVideo

VIDEO: Telemedicine aids treatment of patients with HCV, substance use disorders

April 23, 2017
AMSTERDAM — In this exclusive video from International Liver Congress, Andrew Talal, MD, MPH, from the University of Buffalo, New York…
Meeting News

Shortened duration triple therapy fails in genotype 3 HCV

April 23, 2017
AMSTERDAM — Six weeks of triple combination therapy induced sustained virologic response in a cohort of patients with genotype 1 HCV but not…
Meeting News

Novel NASH treatment reduces hepatic fat, improves liver injury markers

April 22, 2017
AMSTERDAM — A pegylated form of the hormone FGF21 injected subcutaneously produced improvements in hepatic fat, fibrosis markers and metabolic…
Meeting News

Liver stiffness, controlled attenuation may predict decompensation

April 22, 2017
AMSTERDAM — Assessment of liver stiffness and controlled attenuation parameter may be useful as a novel predictor of decompensation, according…
Meeting News

Nearly 80% respond to novel growth factor for NASH

April 22, 2017
AMSTERDAM — With 12 weeks of treatment, more than one-third of biopsy-diagnosed non-alcoholic steatohepatitis patients who received novel…
Meeting News

Ileal bile acid transporter inhibition promising for cholestatic liver disease

April 22, 2017
AMSTERDAM — A novel approach for cholestatic pruritus, ileal bile acid transporter inhibition, was associated with improvement in pruritus in…